Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00897
|
|||||
Drug Name |
Dioscin
|
|||||
Synonyms |
(25R)-spirost-5-en-3beta-yl alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-mannopyranosyl-(1->4)]-beta-D-glucopyranoside; 19057-60-4; 3-O-(Rhaalpha1-4(Rhaalpha1-2)Glcbeta)-(25R)-spirost-5-en-3beta-ol; 3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]-diosgenin; 3-O-[alpha-L-Rhap-(1->4)-[alpha-L-Rhap-(1->2)]-beta-D-Glcp]-diosgenin; 3B95U4OLWV; AC1L3OGN; CCRIS 4123; Collettiside III; Dioscin; Dioscin (Collettiside III); Dioscin(Collettiside III); Dioscine; GTPL840; UNII-3B95U4OLWV
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C45H72O16
|
|||||
Canonical SMILES |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1
|
|||||
InChI |
InChI=1S/C45H72O16/c1-19-9-14-45(54-18-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(52)34(50)32(48)22(4)56-41)37(53)38(29(17-46)58-42)59-40-35(51)33(49)31(47)21(3)55-40/h7,19-22,24-42,46-53H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1
|
|||||
InChIKey |
VNONINPVFQTJOC-ZGXDEBHDSA-N
|
|||||
Pharmaceutical Properties | Molecular Weight | 869 | Topological Polar Surface Area | 236 | ||
Heavy Atom Count | 61 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 16 | |||
XLogP |
1.3
|
|||||
PubChem CID | ||||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.